[Diagnosis and treatment of differentiated thyroid carcinoma].
Mora
J
J
Servicio de Medicina Nuclear, Hospital de Bellvitge. Hospitalet de Llobregat. Barcelona. jmoras@csub.scs.es
D018263:Adenocarcinoma, Follicular / Q000175:diagnosis / Q000453:epidemiology / Q000556:secondary / Q000628:therapy; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood; D002291:Carcinoma, Papillary / Q000175:diagnosis / Q000453:epidemiology / Q000556:secondary / Q000628:therapy; D002454:Cell Differentiation; D002648:Child; D005260:Female; D006801:Humans; D015994:Incidence; D007457:Iodine Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D019275:Radiopharmaceuticals / Q000009:adverse effects / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D013030:Spain / Q000453:epidemiology; D013954:Thyroglobulin / Q000097:blood / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology / Q000628:therapy; D013965:Thyroidectomy; D013974:Thyroxine / Q000627:therapeutic use
D014408:Biomarkers, Tumor; D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D011994:Recombinant Proteins; D013954:Thyroglobulin; D013974:Thyroxine